Saiju Jacob

Jan 16, 2025 | pn.bmj.com | Saiju Jacob

Stiff-person syndrome Free Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Sep 2, 2024 | pn.bmj.com | Saiju Jacob

FootnotesX @SmritiBose99194Contributors Both authors have contributed equally to the concept, writing, revision and approval of the manuscript. Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

May 24, 2024 | nature.com | Saiju Jacob

AbstractMyasthenia gravis (MG) is one of the most well characterised autoimmune disorders affecting the neuromuscular junction with autoantibodies targeting the acetylcholine receptor (AChR) complex. The vast majority of patients present with ocular symptoms including double vision and ptosis, but may progress on to develop generalised fatiguable muscle weakness.

Feb 1, 2024 | onlinelibrary.wiley.com | Michele Veldsman |Adam E. Handel |Saiju Jacob |Paul Maddison

Introduction Leucine-rich glioma-inactivated 1-antibody encephalitis (LGI1-Ab-E) is the commonest form of autoimmune encephalitis (AE) in adults and typically causes seizures, behavioural and cognitive impairment.1, 2 Early immunotherapy often effectively treats seizures and can halt cognitive decline.3 However, longer-term LGI1-Ab-E follow-up studies highlight a potentially severe spectrum of neuropsychological impacts.4, 5 Little is known about which of these impact on quality-of-life (QoL).